Rakovina Therapeutics Inc (RKV)

Currency in CAD
0.54
-0.06(-10.00%)
Closed·
RKV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.540.54
52 wk Range
0.402.25
Key Statistics
Bid/Ask
0.52 / 0.58
Prev. Close
0.54
Open
0.54
Day's Range
0.54-0.54
52 wk Range
0.4-2.25
Volume
500
Average Volume (3m)
1.98K
1-Year Change
-43.16%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RKV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Rakovina Therapeutics Inc Company Profile

Rakovina Therapeutics Inc. is a Canada-based biopharmaceutical company focused on advancing cancer therapies based on novel deoxyribonucleic acid (DNA) damage response (DDR) technologies. The Company’s research programs include kt-2000, kt-3000 and kt-4000 The kt-2000 next generation PARP-inhibitors. The kt-3000 class drug candidates are rationally designed to overcome treatment resistance by selectively downregulating deoxyribonucleic acid (DNA) double-strand (DSB) repair mechanisms while enhancing PARP inhibitor activity. The kt-4000 series lead candidates release a potent methylation agent causing damage to a tumor cell’s DNA while also inhibiting DNA-damage repair mechanisms to cancer cell death.

Compare RKV to Peers and Sector

Metrics to compare
RKV
Peers
Sector
Relationship
P/E Ratio
0.0x0.0x0.0x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.0x0.0x
Price / LTM Sales
0.0x0.0x0.0x
Upside (Analyst Target)
0.0%0.0%0.0%
Fair Value Upside
Unlock0.0%0.0%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

RKV Income Statement

People Also Watch

102.89
CRWV
-5.38%
17.060
QBTS
-3.45%
75.63
OKLO
+6.51%
81.74
MRVL
+7.07%
106.10
HOOD
+2.69%

FAQ

What Stock Exchange Does Rakovina Therapeutics Trade On?

Rakovina Therapeutics is listed and trades on the CBOE Canada Exchange stock exchange.

What Is the Stock Symbol for Rakovina Therapeutics?

The stock symbol for Rakovina Therapeutics is "RKV."

What Is the Rakovina Therapeutics Market Cap?

As of today, Rakovina Therapeutics market cap is 11.84M.

What Is Rakovina Therapeutics's Earnings Per Share (TTM)?

The Rakovina Therapeutics EPS (TTM) is 0.00.

When Is the Next Rakovina Therapeutics Earnings Date?

Rakovina Therapeutics will release its next earnings report on 26 Aug 2025.

From a Technical Analysis Perspective, Is RKV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Rakovina Therapeutics Stock Split?

Rakovina Therapeutics has split 0 times.

What is the current trading status of Rakovina Therapeutics (RKV)?

As of 31 Jul 2025, Rakovina Therapeutics (RKV) is trading at a price of 0.54, with a previous close of 0.54. The stock has fluctuated within a day range of 0.54 to 0.54, while its 52-week range spans from 0.40 to 2.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.